Oscar(US:OSCR) Yahoo Finance·2026-03-07 15:05Core Viewpoint - Oscar Health's CEO Mark Bertolini maintains that the company will achieve profitability by 2026, despite disappointing Q4 2025 results [2][4]. Financial Performance - In Q4 2025, Oscar Health reported an EPS of -$1.24, missing the estimate of -$0.92 by nearly 35% [3]. - The medical loss ratio (MLR) for Q4 was 95.4%, up from 88.1% the previous year, indicating that Oscar spent 95 cents on medical costs for every dollar of premium collected [3]. - Despite the poor financial results, Oscar's stock rose approximately 9.6% following the Q4 announcement, as investors focused on future profitability [3][8]. 2026 Profitability Guidance - Oscar Health anticipates a significant year-over-year improvement of nearly $750 million in earnings from operations in 2026, targeting earnings from operations of $250 million to $450 million, compared to a loss of $396 million in 2025 [4][8]. - The company aims to reduce the MLR to between 82.4% and 83.4% in 2026, a substantial improvement from Q4's 95.4% [5][8]. Strategic Initiatives - Lever One: AI-driven Efficiency Oscar is implementing AI technologies to enhance operational efficiency, with the Agentic AI bot reducing response times by 67% during peak enrollment periods and achieving high accuracy in addressing member inquiries [6]. - Lever Two: Pricing Discipline The company has taken a weighted average rate increase of approximately 28% for 2026, accounting for the expiration of enhanced premium tax credits that inflated enrollment with higher-risk members in 2025 [7]. - Lever Three: Market Share Gains Oscar Health is positioned to gain market share as CVS Health exits the ACA exchange market, which may provide additional opportunities for growth [8].